The a2 Milk Company Limited logo

Ongoing Disclosure Notice – Jayne Hrdlicka

Insider Disclosure3 September 2018ATMConsumer Staples

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

The a2 Milk Company Limited

Date this disclosure made:

3/09/2018

Date of last disclosure:

17/07/2018

Director or senior manager giving disclosure

Full name(s):

Carla Jayne Hrdlicka

Name of listed issuer:

The a2 Milk Company Limited (Company)

Name of related body corporate (if applicable):

N/A

Position held in listed issuer:Managing Director and CEO

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Ordinary Shares

Nature of the affected relevant interest(s):

(1) Legal and beneficial owner of unlisted

time-based rights (representing an

entitlement to acquire Ordinary Shares in the

Company granted to Ms Hrdlicka as a one-

off transition benefit as compensation for the

forfeiture of her short term and long term

incentive entitlements from her former

employer as a result of her resignation to

take up employment with the Company)

(Time-Based Rights); (2) Legal and

beneficial owner of Ordinary Shares

For that relevant interest-


Number held in class before acquisition or disposal:

(1) 599,254 Time-Based Rights; (2) Nil

Ordinary Shares

Number held in class after acquisition or disposal:

(1) 242,022 Time-Based Rights; (2) 357,232

Ordinary Shares (received on automatic

exercise of the equivalent number of Time-

Based RIghts)

Current registered holder(s):Carla Jayne Hrdlicka

Registered holder(s) once transfers are registered:Carla Jayne Hrdlicka

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the underlying

financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-

Date of transaction:

(1) 28/08/2018; (2) 03/09/2018

Nature of transaction:
(1) Issue of 237,090 Ordinary Shares

following the automatic exercise of 237,090

Time-Based Rights, the timing of such

automatic exercise reflecting the vesting

date of the relevant forfeited incentive

entitlements from Ms Hrdlicka's former

employer; (2) Issue of 120,142 Ordinary

Shares following the automatic exercise of

120,142 Time-Based Rights, the timing of

such automatic exercise reflecting the

vesting date of the relevant forfeited

incentive entitlements from Ms Hrdlicka's

former employer

Name of any other party or parties to the transaction (if known):

N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition

or disposal. If the consideration was not in cash and cannot be readily be converted into a

cash value, describe the consideration:

N/A

Number of financial products to which the transaction related:

(1) and (2) 357,232 Time-Based Rights in

aggregate

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Unlisted performance rights representing an

entitlement to acquire Ordinary Shares in the

Company (Performance Rights)

Nature of relevant interest:

Legal and beneficial

For that relevant interest,-

Number held in class:245,787 Performance Rights

Current registered holder(s):Carla Jayne Hrdlicka

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the underlying

financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

3/09/2018

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

Name and title of authorised person:

Notes
Use this form to disclose all the acquisitions and disposals by a director or senior manager

of a listed issuer, or of a related body corporate, or in specified derivatives. The disclosure

must be made within—

(a) 20 working days after the first acquisition or disposal disclosed in this

notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the

Financial Markets Conduct Act 2013; or

(b) in any other case, 5 trading days after the first acquisition or disposal

disclosed in this notice.

---

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 1

Rule 3.19A.2

Appendix 3Y


Change of Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11


Name of entity The a2 Milk Company Limited (Company)

ABN 97 769 415 292


We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for

the director for the purposes of section 205G of the Corporations Act.


Name of Director

Carla Jayne Hrdlicka

Date of last notice

17 July 2018


Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Direct or indirect interest

Direct

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the

relevant interest.

N/A

Date of change

28/08/2018 and 03/09/2018

No. of securities held prior to change

599,254 time-based rights representing an

entitlement to acquire ordinary shares in the

Company (granted to Ms Hrdlicka as a one-

off transition benefit as compensation for the

forfeiture of her short term and long term

incentive entitlements from her former

employer as a result of her resignation to take

up employment with the Company) (Time-

Based Rights)

245,787 performance rights representing an

entitlement to acquire ordinary shares in the

Company (Performance Rights)

Class

Ordinary shares in the Company (Ordinary

Shares)

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


Appendix 3Y Page 2 01/01/2011

Number acquired

237,090 Ordinary Shares acquired on

28/08/2018


120,142 Ordinary Shares acquired on

03/09/2018


Number disposed

237,090 Time-Based Rights disposed of on

28/08/2018 as the result of the issue of

Ordinary Shares upon the automatic exercise

of the equivalent number of Time-Based

Rights


120,142 Time-Based Rights disposed of on

03/09/2018 as the result of the issue of

Ordinary Shares upon the automatic exercise

of the equivalent number of Time-Based

Rights

Value/Consideration

Note: If consideration is non-cash, provide details and estimated

valuation

N/A

No. of securities held after change

242,022 Time-Based Rights

245,787 Performance Rights

357,232 Ordinary Shares

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue

of securities under dividend reinvestment plan, participation in buy-back

Issue of Ordinary Shares following the

automatic exercise of Time-Based Rights, the

timing of such automatic exercises reflecting

the vesting date of the relevant forfeited

incentive entitlements from Ms Hrdlicka's

former employer

Part 2 – Change of director’s interests in contracts


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Detail of contract

n/a

Nature of interest

n/a

Name of registered holder

(if issued securities)

n/a

Date of change

n/a

No. and class of securities to which

interest related prior to change

Note: Details are only required for a contract in

relation to which the interest has changed

n/a

Interest acquired

n/a

Interest disposed

n/a

Value/Consideration

Note: If consideration is non-cash, provide details

and an estimated valuation

n/a

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 3

Interest after change

n/a


Part 3 –

+

Closed period


Were the interests in the securities or contracts detailed

above traded during a

+

closed period where prior written

clearance was required?

No

If so, was prior written clearance provided to allow the trade

to proceed during this period?

n/a

If prior written clearance was provided, on what date was

this provided?

n/a

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • MHJ — Michael Hill International Limited: Senior Manager Notice
    2018-10-28

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Michael Hill International Limited Date this disclosure made: 25-Oct-18 Date of la…”

  • FPH — Fisher & Paykel Healthcare Corporation Limited: D&O Ongoing Disclosure – Paul Shearer
    2018-06-14

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: Thursday,…”

  • NZX — NZX Limited: D&O Ongoing Disclosures – Multiple
    2018-06-14

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 15-Jun-18 Date of last disclosure: 3-May-1…”